Clinical trials: Debriefing

Nasal Polyps

Qualitative Analysis of Subject Experience of Nasal Polyps

• Completed
• Age: 18 years and older
• Observational study
• Results posted

Nasal polyposis is a chronic inflammatory disease of the nose and sinuses. GlaxoSmithKline (GSK) is embarking on a clinical program to assess treatment of severe, recurrent nasal polyps with an anti-interleukin-5 (anti-IL5)…

Trial name

NCT03221192

Testing

VAS questionnaire, SNOT-22 questionnaire, Data capture app

Where

United States

Volunteers

27 people

Sponsor

GlaxoSmithKline